Virginia Polytechnic Institute and State University
vt.eduTotal trials
121
Active
31
Phase 3
1
Total enrollment
16,561
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Cigarette Smoking10
- Prediabetes5
- Alcohol Use Disorder5
- Chronic Pain4
- Overweight and Obesity4
- Autism Spectrum Disorder4
- Cardiovascular Risk Factor4
- Cigarette Smoking Behavior4
Frequently asked questions about Virginia Polytechnic Institute and State University
- How many clinical trials does Virginia Polytechnic Institute and State University have on ClinicalTrials.gov?
- Virginia Polytechnic Institute and State University is listed as the lead sponsor on 121 clinical trials in ClinicalTrials.gov, 31 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Virginia Polytechnic Institute and State University's trials are in Phase 3?
- 1 of Virginia Polytechnic Institute and State University's trials are in Phase 3.
- What therapeutic areas does Virginia Polytechnic Institute and State University focus on?
- Virginia Polytechnic Institute and State University's most-studied conditions on ClinicalTrials.gov are Cigarette Smoking, Prediabetes, Alcohol Use Disorder, Chronic Pain, Overweight and Obesity.